$CSTM

Deslarzes Jean-Christophe purchased $41K of CSTM

Deslarzes Jean-Christophe purchased 1,490 shares of CONSTELLIUM SE (CSTM) at $27.24 on 2026-08-03.

Original reporting
SEC EDGAR · Deslarzes Jean-Christophe
Published Aug 3, 2026, 11:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CSTM
Neutral
medium confidence
Mentioned
$CSTM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSTMNeutralLow
01

Why it matters

A director-level open-market purchase was reported with exact share count, price, and post-transaction holdings, but no other company-specific catalyst is included.

02

Market read

Traders may note the fresh insider buy, but the disclosure lacks additional fundamentals that would justify a high-conviction trade.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the article does not provide context such as prior trading patterns, compensation timing, or whether the buy was funded by liquidity events.

Relevance 4/10Novelty 5/10Timing: filed on 2026-08-03, transaction dated 2026-08-03

Background

This is an SEC Form 4 insider transaction disclosure for Constel­lium SE (CSTM).

Company-level read

Ticker impact

$CSTMNeutralMedium confidence
Context

Constellium SE insider Deslarzes Jean-Christophe bought 1,490 shares on 2026-08-03 at $27.2400 via an open-market purchase.

Expected impact

Low likelihood of a sustained price move; any near-term reaction would be sentiment-driven and typically fades.

Evidence & confidence

Form 4 provides a fresh, primary-source transaction date and price, but the article contains no accompanying guidance, operational update, or material corporate event.

Market effects

No sector-level implications are provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be opportunistic and do not necessarily signal undervaluation, especially when transaction size is small relative to company market cap.

Key entities

  • Constellium SE

    Subject of the Form 4 insider transaction disclosure (CSTM).

  • Deslarzes Jean-Christophe

    Director who reported an open-market purchase of 1,490 shares on 2026-08-03.

Related articles

$CSTMHighAI 9/10

Constellium Raises Full-Year Outlook After Second-Quarter Earnings Top Expectations

Constellium SE (NYSE:CSTM) reported stronger-than-expected second-quarter results on Wednesday and increased its financial guidance for the full year, sending its shares more than 3% higher in pre-market trading. The aluminum products manufacturer posted adjusted earnings of $1.04 per share, comfortably ahead of analysts' consensus estimate of $0.71. Quarterly revenue rose to $2.75 billion, exceeding expectations of $2.37 billion and increasing 31% from $2.1 billion in the same period last year.

$CSTMMedAI 8/10

Constellium SE Q2 2026 Earnings Call Summary

Constellium SE reported record Q2 2026 Adjusted EBITDA of $310 million (excluding metal price lag) and raised full-year 2026 guidance to EUR 980 million to EUR 1.02 billion. It expects free cash flow above EUR 300 million and said recycling benefits may taper in H2 2026. The company also discussed aerospace demand, scrap spreads, and a potential European scrap export tax.

$CSTMMed

CONSTELLIUM SE (CSTM): Results of Operations and Financial Condition

CONSTELLIUM SE (CSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. cstm-20260729 false 0001563411 0001563411 2026-07-29 2026-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

$CSTMMedAI 8/10

Constellium (NYSE:CSTM) Shares Pass Above 200 Day Moving Average – Here’s Why

Constellium SE (NYSE:CSTM) shares moved above their 200-day moving average on Monday, trading up to $33.54 and last at $33.26 versus a 200-day average near $23.72. The stock also saw analyst changes: Zacks upgraded to strong-buy; Deutsche Bank reiterated buy with a $40 target; JPMorgan raised its $34 target. The company reported April 29 EPS of $1.42 and revenue of $2.46B, and approved a $300M buyback.